Stockreport

Rhythm Pharmaceuticals Wins FDA Approval for IMCIVREE in Acquired Hypothalamic Obesity Launch [Yahoo! Finance]

Rhythm Pharmaceuticals, Inc.  (RYTM) 
Last rhythm pharmaceuticals, inc. earnings: 3/8 08:12 am Check Earnings Report
US:NASDAQ Investor Relations: ir.rhythmtx.com
PDF long-term in adults and pediatric patients aged 4 and older with acquired hypothalamic obesity, granting a broad label not limited to tumor-related hypothalamic injury a [Read more]